Ingenol Mebutate API is a pharmaceutical-grade diterpene ester derived from the plant Euphorbia peplus. It has been used in topical dermatological formulations for the treatment of actinic keratosis, a precancerous skin condition caused by prolonged exposure to ultraviolet (UV) radiation.
Ingenol Mebutate exerts its therapeutic action through a dual mechanism involving rapid destruction of abnormal skin cells and activation of local immune responses, helping eliminate dysplastic keratinocytes. It is formulated into topical gels and dermatological preparations for localized skin treatment.
Manufactured under WHO-GMP-certified facilities, our Ingenol Mebutate API is produced using advanced pharmaceutical manufacturing processes to ensure exceptional purity, stability, and batch-to-batch consistency. Every batch undergoes stringent quality testing and is supplied with complete documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and Product Specifications.
Ingenol Mebutate API is used in topical pharmaceutical formulations for the treatment of actinic keratosis and other dermatological research applications.
Ingenol Mebutate rapidly destroys abnormal skin cells while stimulating local immune responses that help eliminate damaged keratinocytes.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every shipment.
Yes. We supply Ingenol Mebutate API in commercial quantities with worldwide export support and customized packaging.
Get Bulk Quote via WhatsApp